Keynote Presentations
Human Genome: Advances in Extracting Useful Data
Yoshihide Hayashizaki, M.D., Ph.D., Director, Omics Science Center, RIKEN, Japan
Eisai Global R&D Strategy
Kentaro Yoshimatsu, Ph.D., Senior Vice President, Research & Development, Eisai Co., Ltd., Japan
Special FDA Presentation
FDA's Strategy for Predictive Toxicology
Donna L. Mendrick, Ph.D., Director, Division of Systems Toxicology, NCTR, U.S. Food and Drug Administration, USA
Benchmark Your R&D Efforts, Find New Markets & Develop Your Drug Hunting Skills
- Improve compound design, optimization and selection using cell-based, biomarker, translational and other technologies
- Learn how to build an antibody and biologics franchise: Hear scientific strategies from worldwide experts
- Explore global progress on RNAi therapeutic development and meet seven top RNAi companies
- Hear how your competitors are expanding their R&D operations outside of Japan and globally
- Connect with potential partners from over 25 North American and European companies
New This Year
- The Antibody Discovery & Protein Science Summit
- Specialized Tutorial on Immunogenicity Prediction
- Two Concurrent Sessions Featuring 50+ Speakers
» View the Entire Conference Agenda
» View these Individual Agendas: